Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chairman, President and CEO, Director
-
Stock Symbol
-
CRL on NYSE
James C. Foster - trading volume in the past year for Charles River Laboratories International, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
184K |
$30.3M |
$165.01 |
Feb 20, 2025 |
Direct |
|
|
Stock Options (Right to Buy) |
24.9K |
$5.18M |
$208.44 |
May 31, 2024 |
Direct |
Common Stock |
|
Common Stock |
20K |
$3.3M |
$165.01 |
Feb 20, 2025 |
2024 GRAT |
|
|
Common Stock |
20K |
$3.3M |
$165.01 |
Feb 20, 2025 |
2025 GRAT |
|
|
Common Stock |
10K |
$1.65M |
$165.01 |
Feb 20, 2025 |
Held By Spouse |
|
|
Common Stock |
9.79K |
$1.62M |
$165.01 |
Feb 20, 2025 |
2023 GRAT |
|
|
Common Stock |
4.05K |
$668K |
$165.01 |
Feb 20, 2025 |
2022 GRAT |
|
|
Common Stock |
2.25K |
$371K |
$165.01 |
Feb 20, 2025 |
By Trust |
|
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.